Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?Janneke Anink, Lisette W. A. van Suijlekom‐Smit, S. S. M. Kamphuis et al.|Lara D. Veeken|2013Cited by 40